The enigmatic helicase DHX9 as a candidate prognostic biomarker for resected pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, and current therapies have limited efficacy on PDAC. The DEAH-box helicase 9 (DHX9) is widely reported to influence cell biological behavior via regulating DNA replication, genomic stability, transcripti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Le-gao, Cui, Ying, Lu, Wei-qin, Wu, Hao, Jiang, Jin-song, Ding, Ke-feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791203/
https://www.ncbi.nlm.nih.gov/pubmed/36578944
http://dx.doi.org/10.3389/fonc.2022.1066717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791203/
https://www.ncbi.nlm.nih.gov/pubmed/36578944
http://dx.doi.org/10.3389/fonc.2022.1066717

Ejemplares similares